tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Harrison, 554 are a BUY (61.83%), 264 are a HOLD (29.46%), 78 are a SELL (8.71%).
Analyst Matthew Harrison, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 66.14% that have a potential upside of 31.22% achieved within 253 days.
Matthew Harrison’s has documented 1,779 price targets and ratings displayed on 93 stocks. The coverage is on Healthcare, Technology, Basic Materials, Energy, Industrials sectors.
Most recent stock forecast was given on R, Ryder System at 13-Feb-2026.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 2/23/2016. The price target of $5 was fulfilled within 1 day with a profit of $0.54 (12.11%) receiving and performance score of 121.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Apr-2021
$7
$2.9 (70.73%)
4 months 7 days ago
(16-Oct-2025)
1/12 (8.33%)
$2.87 (69.49%)
70
Buy Since 28-Mar-2024
$10
$5.9 (143.90%)
$10
6 months 10 days ago
(13-Aug-2025)
0/4 (0%)
$6.91 (223.62%)
Buy Since 10-May-2022
$5
$0.9 (21.95%)
$8
8 months 3 days ago
(20-Jun-2025)
0/9 (0%)
$2.23 (80.51%)
Sell Since 24-Apr-2023
$1
$-3.1 (-75.61%)
$2
2 years 4 months 6 days ago
(17-Oct-2023)
2/4 (50%)
$0.23 (29.87%)
30
Hold Since 10-Aug-2023
$5
2 years 6 months 13 days ago
(10-Aug-2023)
1/2 (50%)
$-0.07 (-1.38%)
2
Which stock is Matthew Harrison is most bullish on?
Which stock is Matthew Harrison is most reserved on?
What Year was the first public recommendation made by Matthew Harrison?
